📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab? (2018)

First Author: Smith-Jackson K

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21037/atm.2018.10.35

PubMed Identifier: 30613637

Publication URI: http://europepmc.org/abstract/MED/30613637

Type: Journal Article/Review

Volume: 6

Parent Publication: Annals of translational medicine

Issue: Suppl 1

ISSN: 2305-5839